Pages that link to "Q43696283"

The following pages link to Prophylactic immunization against experimental leishmaniasis: I. Protection induced in mice genetically vulnerable to fatal Leishmania tropica infection. (Q43696283):

Displaying 31 items.

• Biochemical and biological characterization of the protective Leishmania pifanoi amastigote antigen P-8. (Q33552567) (← links)
• Leishmania pifanoi amastigote antigen P-4: epitopes involved in T-cell responsiveness in human cutaneous leishmaniasis (Q33756069) (← links)
• Leishmaniasis: current status of vaccine development (Q33941719) (← links)
• Immunostimulatory DNA as an adjuvant in vaccination against Leishmania major. (Q34001298) (← links)
• Subunit vaccination of mice against new world cutaneous leishmaniasis: comparison of three proteins expressed in amastigotes and six adjuvants (Q34003547) (← links)
• Perforin and gamma interferon are critical CD8+ T-cell-mediated responses in vaccine-induced immunity against Leishmania amazonensis infection (Q35011520) (← links)
• Patterns of cytokine secretion in murine leishmaniasis: correlation with disease progression or resolution (Q35108546) (← links)
• Leishmania pifanoi amastigote antigens protect mice against cutaneous leishmaniasis (Q35437937) (← links)
• Histopathologic changes induced by vaccination in experimental cutaneous leishmaniasis of BALB/c mice (Q35856367) (← links)
• Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice (Q35949770) (← links)
• A common major surface antigen on amastigotes and promastigotes of Leishmania species (Q36350820) (← links)
• Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens (Q36355614) (← links)
• CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing (Q36446351) (← links)
• Vaccine-induced immunity against cutaneous leishmaniasis in BALB/c mice (Q36995828) (← links)
• Suppression of interleukin-2 production by macrophages in genetically susceptible mice infected with Leishmania major (Q37013127) (← links)
• Effect of T-lymphocyte suppression on the parasite burden in Leishmania major-infected, genetically susceptible BALB/c mice (Q37014350) (← links)
• Characterization of cellular immune response to chemically defined glycoconjugates from Leishmania mexicana subsp. amazonensis (Q37030319) (← links)
• Monoclonal antibodies for serotyping Leishmania strains. (Q37254742) (← links)
• New aspects of vaccine development. (Q38157611) (← links)
• Effect of neonatal injection with antibodies to Leishmania mexicana on its growth in adult infected mice (Q40160016) (← links)
• Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice (Q40163661) (← links)
• Altered virulence and vaccination properties of Leishmania parasites grown in infected vaccinated mice (Q40427732) (← links)
• Surface antigens of Leishmania donovani promastigotes (Q42936466) (← links)
• Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major (Q44235376) (← links)
• Specific immunization of mice against Leishmania mexicana amazonensis using solubilized promastigotes. (Q45240681) (← links)
• Therapeutic immunization with radio-attenuated Leishmania parasites through i.m. route revealed protection against the experimental murine visceral leishmaniasis. (Q53097431) (← links)
• TNF-alpha reverses the disease-exacerbating effect of subcutaneous immunization against murine cutaneous leishmaniasis (Q67774743) (← links)
• Inhibition in vivo of both infective Leishmania major and L. mexicana amazonensis mediated by a single monoclonal antibody (Q69677296) (← links)
• Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis (Q69737033) (← links)
• Cell contact-mediated macrophage activation for antileishmanial defence: mapping of the genetic restriction to the I region of the MHC (Q69978235) (← links)
• The effects of Con A-induced lymphokines from the T-lymphocyte subpopulations on human monocyte leishmanicidal capacity and H2O2 production (Q70015056) (← links)